
|Videos|April 27, 2022
Aurion BioTech presents cell therapy findings with published clinical data
Author(s)Kassi Filkins
Greg Kunst, president and CEO of Aurion BioTech, shares a company update on endothelial cell therapy trials, clinical plans and upcoming data.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ICYMI: AAO 2025 showcases new technologies and continued research
2
Evolving glaucoma therapy: A new era of interventional strategies
3
Q&A: William F. Wiley, MD, on what BVI's trifocal IOL approval means for US premium vision options
4
Precision strategy: Optimizing visual outcomes with advanced small-aperture lenses
5

















































.png)


